research use only

MRTX1133 KRAS-G12D inhibitor

Cat.No.E1051

MRTX1133 is a highly selective inhibitor of mutant KRAS G12D and can reversibly binds to the activated and inactivated KRAS G12D mutants and inhibit their activity. The specificity of MRTX1133 to KRAS G12D is more than 1000 times that of wild-type KRAS.
Jump to

Quality Control

Batch: Purity: 99.410%
99.410
Q&A of MRTX1133: Insights Rooted in Extensive Publications, Every Answer Cited
AI is thinking... 0%

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 100 mg/mL (166.49 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about MRTX1133 solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about MRTX1133 working concentrations for cell culture treatment

×

Selectivity & Specificity

MRTX1133 is a potent inhibitor of KRAS G12D (0.4 nM), ERK1/2, KRAS WT, MAPK cascade, PI3K-AKT-mTOR pathway, RalGEF-Ral pathway, caspase-3, PARP, glutathione, GPX4, pentose phosphate pathway, NADPH, nucleotide synthesis, fatty acid synthesis, fatty acid oxidation, glycolysis, Ki-67, CD8+ T cells, RAF1, ERK, PanIN, EGFR, HER2. MRTX1133 exhibits the greatest inhibitory potency toward KRAS G12D (IC50 = 0.4 nM).

Read more about selectivity & specificity

Mechanism of Action

Information MRTX1133 is a potent, selective, noncovalent KRAS G12D inhibitor. It affects KRAS/MAPK and PI3K/AKT signaling pathways by binding to the KRAS G12D protein, effectively inhibiting tumor cell proliferation, migration, and growth.

Read more about MRTX1133 IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about MRTX1133 Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 600.63 Formula

C33H31F3N6O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 2621928-55-8 -- Storage of Stock Solutions

Read more about storage & stability

MRTX1133 Combination Database

Read more comparative analysis about MRTX1133

×

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.